Legal Representation
Attorney
Maury M Tepper, III
USPTO Deadlines
Application History
49 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 15, 2014 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Dec 15, 2014 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| May 1, 2014 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 30, 2014 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Apr 23, 2014 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Apr 23, 2014 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 5, 2013 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 4, 2013 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Oct 29, 2013 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Oct 29, 2013 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 7, 2013 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 6, 2013 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| May 4, 2013 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| May 4, 2013 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 3, 2012 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 2, 2012 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 31, 2012 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Nov 2, 2012 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Oct 31, 2012 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 5, 2012 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 3, 2012 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 3, 2012 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 3, 2012 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 8, 2011 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 13, 2011 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 13, 2011 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 8, 2011 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Aug 8, 2011 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 27, 2011 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 27, 2011 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 27, 2011 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 27, 2011 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 27, 2011 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jul 1, 2011 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 1, 2011 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 1, 2011 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 16, 2011 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 16, 2011 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 16, 2011 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 25, 2011 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 25, 2011 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 25, 2011 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 17, 2010 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 17, 2010 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 17, 2010 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 17, 2010 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 14, 2010 | MDSC | O | NOTICE OF DESIGN SEARCH CODE MAILED | Loading... |
| Sep 11, 2010 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 11, 2010 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Anti-infectives; Antibiotic preparations; Antifungal preparations; Antivirals; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the prevention and treatment of inflammatory disorders; Pharmaceutical preparations for the prevention and treatment of disorders or diseases in the fields of dermatology, ophthalmology, oncology, hematology and in tissue and organ transplantation, and for the treatment of gastroenterological disorders
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of two curved lines leading up to a stylized star to the left and above the word "GILENYA"; the color gray is intended to show shading or contrast only.
Color Claim
Color is not claimed as a feature of the mark.
Translation
The wording "GILENYA" has no meaning in a foreign language.
Classification
International Classes
005